You have read all your free articles, to continue reading subscribe to read the rest of this content.
Immunicum announces an update on its Phase I/II study in liver cancer and reports that the first patient in the extended part of the study has been treated with the cancer immune primer. The first patient in the extended part of the study has been treated in the firstline setting with the canAlready a…
The US Food and Drug Administration, FDA, has issued a safety alert to patients and health care professionals, regarding an increased risk of death associated with Pepaxto (melphalan flufenamide), in the OCEAN study. The company has an ongoing dialogue with the FDA and will provide updated informAlready a subscriber Login…
The US Food and Drug Administration has approved Lynparza (olaparib), for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy Already a subscriber Login You have read all your free articles, to continue reading…
The Research Council of Norway is encouraging a variety of Norwegian research groups to take part in a broad-based dialogue on nanotechnology and the opportunities it holds for medical applications. “Nanotechnology holds great potential for new applications in areas such as diagnostics, personaAlready a subscriber Login You have read all…
